Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
Francesco Bartoli, Błażej Misiak, Tommaso Callovini, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3419-3429
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression
Zhiming Li, Jianbo Lai, Peifen Zhang, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 10, pp. 4123-4135
Closed Access | Times Cited: 130
Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities
Miguel Á. Ortega, Miguel Ángel Alvarez-Mon, Cielo García‐Montero, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2645-2673
Open Access | Times Cited: 71
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Myles Corrigan, Aoife M. O’Rourke, Barry Moran, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 49
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Activated Tryptophan-Kynurenine metabolic system in the human brain is associated with learned fear
Maria Rita Battaglia, Chiara Di Fazio, Simone Battaglia
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 42
A role of gut–microbiota–brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice
Yong Yang, Akifumi Eguchi, Xiayun Wan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110652-110652
Open Access | Times Cited: 40
Probiotics, Live Biotherapeutic Products (LBPs), and Gut-Brain Axis Related Psychological Conditions: Implications for Research and Dietetics
Duygu Ağagündüz, Elif Çelik, Özge Cemali, et al.
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 4, pp. 1014-1031
Closed Access | Times Cited: 28
Microbial-Derived Tryptophan Metabolites and Their Role in Neurological Disease: Anthranilic Acid and Anthranilic Acid Derivatives
Claire Shaw, Matthias Hess, Bart C. Weimer
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1825-1825
Open Access | Times Cited: 28
The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
Timothy B. Meier, Jonathan Savitz
Biological Psychiatry (2021) Vol. 91, Iss. 5, pp. 449-458
Open Access | Times Cited: 52
An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway
Laiba Jamshed, Amrita Debnath, Shanza Jamshed, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6300-6300
Open Access | Times Cited: 35
The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
Abbas F. Almulla, Yanin Thipakorn, Asara Vasupanrajit, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100537-100537
Open Access | Times Cited: 35
Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder
Yang Du, Ji-Hui Dong, Lei Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 32
Biomarkers of bipolar disorder based on metabolomics: A systematic review
Jin Chen, Nousayhah Amdanee, Xiaowei Zuo, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 492-503
Closed Access | Times Cited: 8
Comprehensive Bibliometric Analysis of the Kynurenine Pathway in Mood Disorders: Focus on Gut Microbiota Research
Xiuqing Zhu, Jinqing Hu, Shuhua Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings
Ming Li, Tao Li, Xiao Xiao, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 7, pp. 2927-2939
Closed Access | Times Cited: 27
Association between toxoplasmosis and bipolar disorder: A systematic review and meta-analysis
Giulia Cossu, Antonio Preti, Davide Gyppaz, et al.
Journal of Psychiatric Research (2022) Vol. 153, pp. 284-291
Closed Access | Times Cited: 26
C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder
Haixia Zheng, T. Kent Teague, Fang‐Cheng Yeh, et al.
Brain Behavior and Immunity (2022) Vol. 105, pp. 180-189
Open Access | Times Cited: 25
Blood concentrations of neopterin and biopterin in subjects with depression: A systematic review and meta-analysis
Daniele Cavaleri, Francesco Bartoli, Chiara Alessandra Capogrosso, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110633-110633
Closed Access | Times Cited: 23
The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
Adriano José Maia Chaves Filho, Capri Eyres, Leonie Blöbaum, et al.
Journal of Neurochemistry (2024)
Open Access | Times Cited: 6
Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
Antonella Campanale, Antonio Inserra, Stefano Comai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111058-111058
Open Access | Times Cited: 6
Immune-based Machine learning prediction of diagnosis and illness state in schizophrenia and bipolar disorder
Katrien Skorobogatov, Livia De Picker, Ching‐Lien Wu, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 422-432
Open Access | Times Cited: 6
The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its Catabolites
Daniele Cavaleri, Cristina Crocamo, Pietro Morello, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 583-583
Open Access | Times Cited: 5
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Stefano Comai, Nicolás A. Núñez, Tobias Atkin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine
Daniele Cavaleri, Ilaria Riboldi, Cristina Crocamo, et al.
Neuroscience Letters (2024) Vol. 831, pp. 137791-137791
Open Access | Times Cited: 5
Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
Francesco Bartoli, Daniele Cavaleri, Bianca Bachi, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 230-238
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top